发明名称 Pharmacologically active CNS compounds.
摘要 <p>The invention provides a series of compounds of formula (I) &lt;CHEM&gt; and salts thereof, wherein for example, R&lt;1&gt; and R&lt;2&gt;, which may be the same or different each represent -NR&lt;1&gt;&lt;3&gt;R&lt;1&gt;&lt;4&gt; where R&lt;1&gt;&lt;3&gt; and R&lt;1&gt;&lt;4&gt; may each independently represent hydrogen or alkyl or, taken together with the nitrogen atom to which they are attached form a heterocyclic ring, optionally substituted by one or more alkyl or arylalkyl groups and optionally containing a further heteroatom; R&lt;3&gt; is hydrogen, haloalkyl, alkoxymethyl or alkyl; R&lt;4&gt; is hydrogen, nitro or halo; R&lt;5&gt; is hydrogen or halo; R&lt;6&gt; is hydrogen, halo, nitro, amino, alkylamino or dialkylamino; R&lt;7&gt; is hydrogen or halo; R&lt;8&gt; is hydrogen or halo; The compounds may be used for the treatment or prophylaxis of a neurodegenerative or other neurological disorder of the CNS, the aetiology or which includes excessive release of the neurotransmitter glutamate.</p>
申请公布号 EP0459819(A2) 申请公布日期 1991.12.04
申请号 EP19910304935 申请日期 1991.05.31
申请人 THE WELLCOME FOUNDATION LIMITED 发明人 LEACH, MICHAEL JOHN;NOBBS, MALCOLM STUART;IYER, RAMACHANDRAN;YEATES, CLIVE LEONARD;SKONE, PHILIP ALAN
分类号 A61K31/535;A61K31/505;A61K;A61K31/13;A61K31/445;A61P9/10;A61P25/00;A61P25/28;C07D;C07D239/28;C07D239/42;C07D239/48;C07D401/04;C07D403/04;C07D413/04 主分类号 A61K31/535
代理机构 代理人
主权项
地址